Pharmaceutical Engineering • Facility Contamination Control

HVAC System Design for Sterile and Non-Sterile Pharmaceutical Facilities

Pharmaceutical HVAC design is not a one-size-fits-all exercise. A sterile filling suite, a non-sterile tablet area, a potent-compound room and a warehouse have different contamination, containment and environmental-control needs. A suitable design translates process risks and user requirements into room zoning, airflow, filtration, pressure relationships, temperature and humidity control, monitoring and maintainable equipment. This guide explains the design principles that shape HVAC systems across sterile and non-sterile pharmaceutical facilities.

Sterile manufacturingNon-sterile manufacturingPressure strategyRisk-based design

Quick answer: HVAC design for pharmaceutical facilities begins with product and process risks, then defines room cleanliness, pressure direction, airflow, filtration, temperature/RH, monitoring, alarms and maintenance access. Sterile areas require controls that support the contamination-control strategy and cleanroom classification; non-sterile areas need environmental control appropriate to product exposure, process sensitivity and cross-contamination risks. Pressure direction must be selected for the specific hazard: positive pressure may protect product from ingress, while negative pressure may be needed for containment. Design values and acceptance criteria must be justified for the site rather than copied as universal numbers.

Start with riskDefine product, process, personnel and environmental hazards.

Design the zoningPlan room adjacencies, airlocks, pressure cascades and material/personnel flows.

Engineer controlsSelect air treatment, distribution, controls, alarms and monitoring based on function.

Plan the lifecycleDesign for qualification, operation, maintenance and future change.

What Does Pharmaceutical HVAC Design Need to Achieve?

Heating, ventilation and air-conditioning systems condition and distribute air to maintain room environments. In pharmaceutical facilities, their design may support several objectives at once:

• Protect exposed products and materials from airborne contamination.
• Reduce cross-contamination between products, processes or rooms.
• Contain dust, potent materials, solvents or other hazards where needed.
• Maintain room cleanliness and environmental conditions appropriate to use.
• Support personnel comfort and safe working conditions without compromising product or containment controls.
• Provide reliable monitoring, alarms and records that enable operators to respond to excursions.
• Allow practical inspection, cleaning, filter change, calibration and maintenance.

The design basis should state which objectives apply to each room. WHO guidance for non-sterile pharmaceutical HVAC emphasizes defined environmental conditions, prevention of unfiltered-air infiltration, airflow and filtration design, and lifecycle management. EU GMP Annex 1 sets sterile manufacturing expectations within the EU GMP framework. See the current WHO TRS 1010 Annex 8 and EudraLex Volume 4.

Key Differences Between Sterile and Non-Sterile HVAC Design

Design topic	Sterile facility emphasis	Non-sterile facility emphasis
Primary design objective	Support contamination control and protect sterile product, components and critical operations.	Control airborne contamination, cross-contamination and environmental conditions in proportion to process and product risks.
Room classification	Cleanroom grades/classifications and states are established for defined operations under applicable sterile GMP requirements.	Controlled environments are defined according to products, processes, exposure and risk; classification is not automatically required for every room.
Airflow strategy	Air supply, return and unidirectional airflow (where used) are designed to protect critical zones and avoid adverse flow patterns.	Air distribution is selected to maintain appropriate room conditions, dilute/remove contaminants and prevent unwanted transfer.
Pressure relationships	Pressure cascades help control contamination direction; product protection and containment needs must both be considered.	Positive or negative pressure is selected based on ingress, product, dust, potent-material and operator/environment protection risks.
Filtration	Filtration stages and terminal HEPA filtration are selected where needed for the classified area and process; integrity and monitoring strategy are defined.	Filter stages are selected to meet air cleanliness and equipment protection requirements, with HEPA use determined by risk and design.
Monitoring and qualification	Qualification and ongoing monitoring reflect room grade, operations, critical zones and contamination-control strategy.	Testing and monitoring are tailored to environmental requirements, product/process risk and applicable GMP expectations.
Operational complexity	More stringent controls may be needed for gowning, airlocks, interventions, recovery, alarm response and aseptic activities.	Controls vary by dosage form and exposure; dusty operations, potent products and moisture-sensitive products may require specialized zoning.

Key design principle: “Sterile” and “non-sterile” are not complete HVAC specifications. Design from room function, process exposure, product sensitivity, hazard containment and the applicable regulatory framework.

Design Inputs: Information to Establish Before Layout and Equipment Selection

A robust design starts with a cross-functional design brief. Avoid selecting air-change rates, pressure differentials or filter configurations before the intended use and design constraints are understood.

• Products and materials handled, including sensitivity to particles, moisture, temperature or contamination.
• Process steps, open-product exposure, aseptic operations, dust generation, solvent use and heat loads.
• Room classification or cleanliness targets and whether these apply at rest, operationally or both.
• Personnel and material flows, equipment movement, cleaning practices and waste routes.
• Containment and occupational exposure requirements, including potent or sensitizing compounds.
• Room dimensions, envelope leakage, ceiling heights, adjacent spaces and outdoor design conditions.
• Required operating modes, occupancy, shift patterns, room shutdown or setback strategy.
• Critical environmental parameters, alarms, trend records and monitoring response expectations.
• Available utilities, electrical redundancy, controls architecture, maintainability and expansion plans.
• Regulatory markets, site cGMP commitments and facility contamination-control strategy.

Translate these inputs into a documented User Requirement Specification (URS). The URS should be measurable enough to support design review and later qualification without prescribing unnecessary engineering details prematurely.

Room Zoning, Adjacencies and Airlocks

Room layout and HVAC design should be developed together. Adjacencies influence pressure cascades, airlock function, personnel movement, material transfer and the opportunity for cross-contamination. Separate incompatible activities where needed and avoid creating shortcuts that undermine the intended flow.

Map personnel and material movement

Draw the movement of operators, raw materials, intermediates, components, waste and maintenance tools. Identify where gowning, de-gowning, pass-throughs and airlocks are needed. Consider door-opening frequency and how doors affect pressure stability.

Design airlocks for their intended use

Airlocks may support personnel or material transfer, pressure control, segregation or gowning. Define operating sequence, interlocks, door status and any pressure monitoring needed. The room pressure scheme must remain meaningful during routine use, not only when doors remain closed for a test.

Consider pressure cascade direction at interfaces

A cascade is a design decision driven by risk. For example, a pressure relationship may be intended to reduce ingress into a cleaner area, while a contained room may require inward airflow to protect surrounding spaces. Where both product protection and containment are important, the design may require a dedicated solution such as a pressure bubble/sink, local extraction or segregated air system. Resolve these objectives through documented risk assessment and engineering review.

Pressure Strategy: Product Protection and Containment

Pressure differentials can influence the direction of air leakage between rooms. A positive pressure relative to a less clean adjacent area can help reduce ingress, while a negative pressure can help keep hazardous dust or aerosols from escaping. Neither direction is universally correct across all rooms.

For each boundary, document:

• Which room or zone should be protected and from what hazard.
• Whether the priority is product protection, personnel protection, environmental containment or a defined balance.
• Door states and operating conditions under which the relationship must be maintained.
• How the differential is measured, displayed, alarmed and responded to.
• What happens during fan failure, door opening, utility loss or a pressure sensor fault.
• How pressure relationships will be confirmed during qualification and monitored in operation.

WHO HVAC guidance discusses pressure relationships and controlled airflow; it also recognizes that negative-pressure facilities require special precautions where they differ from normal positive pressure relative to outdoors. Build the chosen approach into the design basis and confirm it with testing. Do not use a generic pressure number as a substitute for design justification.

Air Filtration and Air Distribution

Filter selection should reflect the incoming air quality, process risk, cleanroom classification, protection needs of downstream equipment and the intended terminal performance. A typical system may use staged filtration to protect coils and terminal filters, but the stages and efficiencies must be determined by the facility design.

Filter design considerations

• Choose filter stages appropriate to the required air cleanliness and system arrangement.
• Define filter housing, sealing, access, safe replacement and waste-handling arrangements.
• Specify differential-pressure measurement or condition monitoring where required.
• Provide a documented installation and integrity-testing strategy for terminal HEPA filters where applicable.
• Prevent bypass around filter frames and ensure the housing is accessible for inspection and testing.
• Assess supply, return and exhaust filtration needs based on contamination and containment risk.

Air distribution design

Supply and return locations should support intended airflow direction and avoid stagnant regions, short-circuiting or patterns that carry contaminants across critical product zones. Evaluate the impact of equipment, operators, doors and process interventions. In sterile critical zones, airflow visualization may be used to demonstrate that flow patterns support protection during representative operations.

Temperature, Relative Humidity and Process Loads

Environmental limits should be based on product and process requirements, personnel needs, equipment performance and applicable standards. HVAC systems should maintain the defined operating range under representative loads and seasonal conditions. Avoid specifying tight limits without a demonstrated process need; overly narrow bands can create unnecessary alarms, energy use and control instability.

Designers should account for:

• People, lighting, motors and process equipment heat loads.
• Moisture sources such as washdown, humidification, open liquids and personnel.
• Latent loads from outdoor air and infiltration.
• Temperature or RH stratification, sensor location and response time.
• Potential condensation on surfaces, coils, ducts or cold process equipment.
• Product-specific sensitivity, such as hygroscopic powders or temperature-sensitive materials.
• Mapping or monitoring needs to demonstrate room distribution and identify worst-case locations.

Fresh Air, Recirculation and Exhaust

Outside-air quantity and recirculation strategy affect energy use, humidity control, contamination risk and pressure balance. Evaluate recirculation based on the material handled, contaminant generation, filtration, exhaust arrangement and applicable regulatory requirements. Some hazards may require dedicated exhaust or air systems rather than recirculation.

• Locate outdoor air intakes away from exhaust outlets, loading areas and contamination sources.
• Assess exhaust discharge location and potential re-entrainment into intakes or occupied areas.
• Determine where recirculation is appropriate and what risk controls are needed.
• Use dedicated exhaust or containment systems when the hazard assessment calls for them.
• Provide balancing and commissioning provisions for supply, return and exhaust systems.
• Design access for duct inspection and cleaning where the contamination-control strategy requires it.

Controls, Monitoring and Alarm Design

Control systems should maintain specified operating conditions and provide useful indication when critical conditions are not met. Separate control functions from monitoring or reporting functions where doing so improves independence, reliability or record quality; integration can also be appropriate when designed and qualified correctly.

Control or monitoring feature	Design question	Evidence to plan
Critical sensors	Are range, accuracy, location and response suitable for the decision they support?	Approved sensor schedule, calibration strategy and qualification checks.
Alarms	Will limits, delays, priorities and recipients drive the correct response?	Alarm matrix, challenge test, escalation and response SOP.
Operating modes	What happens in startup, normal operation, standby, maintenance and recovery?	Sequence of operation and mode-specific functional tests.
Failure behavior	How does the system respond to sensor, fan, power or communication failure?	Failure-mode assessment, interlock tests and contingency instructions.
Data and records	Which readings, alarms and changes are GMP records and how are they retained?	Data-flow map, access control, audit trail and backup/restore evidence.

Where electronic records support GMP decisions, apply the site’s ALCOA+ data integrity approach and computerized-system controls.

Designing for Qualification and Maintenance

Qualification becomes more difficult when equipment cannot be accessed, sensors are poorly located or the design omits test ports. Include testing and service needs during design rather than trying to add them after construction.

• Provide access doors, safe platforms and clearance for filter change and instrument calibration.
• Identify test ports and suitable locations for airflow measurement and HEPA integrity testing where relevant.
• Provide drain pan access, cleanable surfaces and service clearances.
• Use clear equipment tags, air-flow direction labels and up-to-date schematic drawings.
• Include provisions for isolation, safe maintenance and return to service.
• Plan spare capacity or redundancy where the consequence of a single failure warrants it.
• Define standard operating modes, alarm response and maintenance boundaries.
• Ensure design decisions support IQ/OQ/PQ execution and post-change verification.

Plan design reviews and Design Qualification (DQ) early. The installed system should later be verified through appropriate IQ, OQ and PQ evidence. See the broader guide to HVAC Validation in Pharmaceuticals.

HVAC Design Lifecycle: A Practical Sequence

1. Understand facility use: document dosage forms, process exposure, hazards, room states and applicable regulations.
2. Perform risk assessment: identify contamination, cross-contamination, containment and environmental risks.
3. Develop the URS and design basis: set functional requirements and traceable environmental needs.
4. Create zoning and room pressure concepts: coordinate architecture, process flows, airlocks and utility strategy.
5. Size and select systems: model loads, air distribution, filtration, exhaust, controls, redundancy and energy impacts.
6. Review design and qualify the design: resolve safety, quality, maintainability and testability before procurement and construction.
7. Commission, qualify and balance: verify installation, sequences, critical alarms and performance against approved requirements.
8. Operate, monitor and maintain: trend performance, investigate excursions, manage changes and periodically review the qualified state.

Common HVAC Design Errors

• Copying room pressure, air-change or temperature values from another facility without a product/process rationale.
• Assuming every sterile or non-sterile room requires the same pressure direction.
• Ignoring containment needs when establishing positive pressure for product protection.
• Designing airlocks and door sequences without considering actual personnel and material movement.
• Placing supply and return points without evaluating flow patterns around equipment and operators.
• Using one HVAC system for incompatible processes without a robust segregation and risk rationale.
• Providing insufficient access for filter changes, calibration, maintenance or qualification tests.
• Failing to define alarm ownership, response times, data retention and excursion escalation.
• Assuming a cleanroom grade alone defines all HVAC design criteria.
• Leaving future changes, expansion or equipment heat loads out of the design basis.

Frequently Asked Questions

What is the main difference between sterile and non-sterile pharmaceutical HVAC design?

Sterile HVAC is designed to support a contamination-control strategy and protect critical aseptic operations under applicable sterile GMP requirements. Non-sterile HVAC is designed around the cleanliness and environmental controls needed for the specific product, process and cross-contamination risks.

Do all pharmaceutical rooms need positive pressure?

No. Pressure direction depends on the hazard and design objective. Positive pressure may help protect product from ingress; negative pressure may be needed for containment. The facility should document and qualify the selected pressure strategy.

Does every non-sterile facility require cleanroom classification?

No. The manufacturer defines a controlled environment appropriate to product and process risks. Formal classification should be applied where required or justified by the facility’s intended use and applicable standards.

Is HEPA filtration required in every pharmaceutical HVAC system?

Not automatically. Filter type and location depend on cleanliness needs, process exposure, room classification, contamination risk and system design. Sterile classified areas commonly have specific filtration needs, but each application should be assessed.

Which parameters should be included in a pharmaceutical HVAC design?

Potential parameters include airflow volume or velocity, pressure relationships, temperature, relative humidity, filtration, alarms, monitoring and room cleanliness. Select them based on requirements and risk rather than applying a fixed universal list.

Why should HVAC design be coordinated with building architecture?

Room dimensions, doors, ceilings, service spaces, wall penetrations and material/personnel routes affect airflow, pressure, access and maintainability. Coordinated design reduces rework and helps the system perform as intended.

What should a pharmaceutical HVAC URS include?

It should define intended use, room environmental needs, critical functions, operating modes, alarms, monitoring, records, maintainability and applicable interfaces. Requirements should be clear enough to verify during design review and qualification.

How are HVAC design values confirmed?

Values are set from approved requirements, engineering calculations, product/process needs, risk assessment and applicable standards. Qualification then verifies the installed system against approved acceptance criteria.

How do HVAC systems support containment?

Containment may rely on pressure direction, exhaust, local extraction, airlocks, filtration and operational controls. The combination should be selected through hazard assessment and verified under representative conditions.

When should the HVAC design be re-evaluated?

Review the design when products, processes, room layouts, equipment loads, hazards, environmental trends or regulations change, or when performance data and deviations indicate that current controls may no longer be adequate.

Conclusion

HVAC system design for sterile and non-sterile pharmaceutical facilities must begin with the product, process and room risks. Sterile manufacturing places strong emphasis on contamination control and critical operations; non-sterile areas still require disciplined environmental and cross-contamination controls tailored to their use. A well-documented design basis, thoughtful pressure strategy, appropriate filtration and airflow, qualified controls, accessible maintenance and traceable requirements create a system that can be tested and sustained throughout its lifecycle.

Related articles

• HVAC Validation in Pharmaceuticals
• User Requirement Specification (URS) and Design Qualification (DQ)
• IQ, OQ and PQ
• cGMP

References and Further Reading

• World Health Organization, TRS 1010, Annex 8: Guidelines on heating, ventilation and air-conditioning systems for non-sterile pharmaceutical products. Official WHO publication page.
• World Health Organization, TRS 1019, Annex 2: Interpretation of guidelines on HVAC systems for non-sterile pharmaceutical products. Official WHO publication page.
• European Commission, EudraLex Volume 4: EU Guidelines for Good Manufacturing Practice, including Annex 1 for sterile medicinal products. Official EudraLex page.

This article is an educational overview, not a facility-specific design specification. Apply current regulations, engineering analysis, approved URS, risk assessment and qualified Quality/Engineering review when designing or modifying pharmaceutical HVAC systems.